Metabolic engineered cells for jasmonic acid biosynthesis

By overexpressing the polypeptide with 12-oxo plant dienolate reductase (OPR) activity in host cells, the efficient biosynthesis of jasmonic acid is achieved, solving the problem of less understanding of fungal biosynthesis pathways and low yields, improving the The production efficiency of jasmonic acid.

CN119032168APending Publication Date: 2024-11-26SUMITOMO CHEM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380034259.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-15
Filing Date
2023-04-06
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

In traditional methods, the production of jasmonic acid in conventional fermentation tank devices has challenges, and the fungal morphology is highly correlated with yield, and the fungal biosynthesis pathway is less understood, resulting in low industrial production efficiency of jasmonic acid.

Method used

By constructing recombinant host cells, overexpressing polypeptides with 12-oxo plant dienolate reductase (OPR) activity is used to perform the biosynthesis of jasmonic acid, including culturing in host cells and recycling of jasmonic acid.

Benefits of technology

Improves the productivity of jasmonic acid, increases maximal specific productivity by at least 50% compared to parent host cells, and provides a more efficient biosynthesis method that overcomes the problems related to fungal morphology and yield in traditional methods.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005085123280000011
    Figure BDA0005085123280000011
  • Figure BDA0005085123280000321
    Figure BDA0005085123280000321
  • Figure BDA0005085123280000322
    Figure BDA0005085123280000322
Patent Text Reader

Abstract

The present invention relates in certain aspects to host cells comprising a jasmonic acid producing metabolic pathway. The host cell overexpresses a polypeptide having 12-oxophytodienoic acid reductase (OPR) activity relative to the corresponding parent host cell.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The field of the invention relates to cells, enzymes and processes useful for producing jasmonic acid molecules. More specifically, the disclosure relates to recombinant host cells that overexpress a polypeptide having 12-oxophytodienoate reductase (OPR) activity relative to a corresponding parent host cell. Background Art

[0002] The production of chemicals by cell culture is an important application of biotechnology. In general, the steps to develop such bioproduction methods may include (1) selecting appropriate host cells, (2) eliminating metabolic pathways that lead to undesirable byproducts, (3) deregulating the desired pathway at both the enzyme activity level and the transcriptional level, and (4) overexpressing appropriate enzymes in the desired pathway.

[0003] Jasmonic acid ("JA") is an organic compound with the chemical formula C6H6O2. It and its derivatives are commonly referred to as "jasmonates" and have many applications in agriculture, flavors and fragrances, and biopharmaceuticals. Traditionally, filamentous fungi have been the only commercially viable source for the biosynthesis of jasmonates. However, yields tend to be highly correlated with fungal morphology, which presents a huge challenge for jasmonic acid production in conventional fermenter units.

[0004] It is believed that higher plants Figure 4 The biosynthetic pathway for the synthesis of jasmonic acid is outlined in . The enzyme 12-oxophytodienoate reductase (OPR, EC 1.3.1.42) catalyzes the reduction of 12-oxophytodienoic acid (12-OPDA) to 3-oxo-2-(cis-2'-pentenyl)-cyclopentane-1-octanoic acid (OPC8), which is a key step in the biosynthetic pathway of jasmonic acid:

[0005]

[0006] OPR belongs to the old yellow enzyme (OYE) family and utilizes NADPH and flavin mononucleotide (FMN) for the reduction of the double bond of OPDA (Schaller and Weiler, 1997). Plant OPR enzymes dedicated to jasmonic acid biosynthesis have been well characterized and the corresponding genes have been cloned (Schaller and Weiler, 1997). In contrast, despite the fact that jasmonic acid as a natural product was first isolated from the filamentous fungal species Lasiodiplodia theobromae (Aldridge et al., 1971), relatively little is known about the fungal pathway for jasmonic acid biosynthesis.

[0007] Recent studies have shown that, similar to higher plants, fungi also use allene oxide and OPDA as key intermediates in JA biosynthesis (Oliw and Hamberg, 2017), indicating that homology searches can be used to identify fungal counterparts of plant genes related to the biosynthesis of jasmonic acid. However, it has been demonstrated that the mechanism of cyclopentenone reduction in D. theobrominum is different from that in plants. In plants, the reduced flavin cofactor appears to be located on the α-face of the OPDA side chain, while in known fungal enzymes, this is present on the β-face of the cyclopentenone plane (Tsukada et al., 2010). Such differences in the stereoselectivity of cyclopentenone olefin reduction in plant and fungal OPR enzymes may suggest differences in their sequence and structure.

[0008] Citation List

[0009] Non-patent literature

[0010] [NPL1] Aldridge DC, Galt S, Giles D and Turner WB. (1971) Metabolites of Lasiodiplodia theobromae. Journal of the Chemical Society C: 1623-1627.

[0011] [NPL2] Ando A, Sumida Y, Ngoro H, Suroto DA et al (2009) Establishment of Agrobacterium tumefaciens-mediated transformation of an oleaginous fungus, Mortierella alpina 1S-4, and its application for eicosapentaenoic acidproducer breeding. Appl. Environ. Microbiol. 75:5529-5535.

[0012] [NPL3] de Groot MJ, Bundock P, Hooykaas PJ and Beijersbergen AG (1998). Agrobacterium tumefaciens-mediated transformation of filamentousfungi. Nat. Biotechnol. 16:839-842.

[0013] [NPL4]dos Reis MC, Pelegrinelli Fungaro MH, Delgado Duarte RT, Furlaneto L et al. (2004). Agrobacterium tumefaciens-mediated genetic transformation of the entomopathogenic fungus Beauveria bassiana. J. Microbiol. Methods 58:197-202.

[0014] [NPL5]Hoekema A, Hirsch PR, Hooykaas PJJ and Schilperoort RA (1983) A binary plant vector strategy based on separation of vir- and T-region of the Agrobacterium tumefaciens Ti-plasmid. Nature 303:179-180.

[0015] [NPL6]Muniz CR, Freire FCO, Viana FMP, Cardoso JE et al. (2012). Polyclonal antibody-based ELISA in combination with specific PCR amplification of internal transcribed spacer regions for the detection and quantitation of Lasiodiplodia theobromae, causal agent of gummosis in cashew nut plants. Ann. Appl. Biol. 160:217-224.

[0016] [NPL7]Muniz CR, da Silva GF, Souza MT, Freire FCO, Kema GHJ, and Guedes MIF (2014) Agrobacterium tumefaciens-mediated transformation of Lasiodiplodia theobromae, the causal agent of gummosis in cashew nut plants. Genet. Mol. Res. 13(2):2906-2913.

[0017] [NPL8]Oliw EH, Hamberg M. (2017) An allene oxide and 12-oxophytodienoic acid are key intermediates in jasmonic acid biosynthesis by Fusarium oxysporum. J Lipid Res. 58:1670-1680.

[0018] [NPL9]Schaller F, Weiler EW. (1997) Molecular cloning and characterization of 12-oxophytodienoate reductase, an enzyme of the octadecanoid signaling pathway from Arabidopsis thaliana. Structural and functional relationship to yeast old yellow enzyme. J Biol Chem. 272:28066-28072.

[0019] [NPL10]Sharma KK and Kuhad RC (2010). Genetic transformation of lignin degrading fungi facilitated by Agrobacterium tumefaciens. BMC Biotechnol. 10:67.

[0020] [NPL11] Staats CC, Junges A, Fitarelli M, Furlaneto MC et al (2007). Geneinactivation mediated by Agrobacterium tumefaciens in the filamentous fungiMetarhizium anisopliae.Appl.Microbiol.Biotechnol.76:945-950.

[0021] [NPL12] Tsukada K, Takahashi K, Nabeta K. (2010) Biosynthesis of jasmonicacid in a plant pathogenic fungus, Lasiodiplodia theobromae. Phytochemistry.71:2019-2023.

[0022] [NPL13] Vieira AL and Camilo CM (2011) Agrobacterium tumefaciens-mediated transformation of the aquatic fungus Blastocladiella emersonii. Fungal. Genet. Biol. 48:806-811.

[0023] [NPL14] Zheng P, Chen PC, Dong WH), 2019, Lasiodiplodia iranensis (A strain of Lasiodiplodia iranensis and its use for the production of jasmonic acid). Chinese patent CN107227264B (Chinese). SUMMARY OF THE INVENTION

[0025] In a first aspect, the invention provides a recombinant host cell comprising a metabolic pathway for producing jasmonic acid. The host cell overexpresses a polypeptide having 12-oxophytodienoate reductase (OPR) activity relative to a corresponding parent host cell. The polypeptide comprises an amino acid sequence having at least 90% identity to the amino acid sequence shown in SEQ ID NO: 1.

[0026] In a second aspect, the present invention encompasses a biosynthetic method for producing jasmonic acid, comprising: culturing a recombinant host cell according to the first aspect above; and recovering jasmonic acid from at least one of the recombinant cell and the culture medium.

[0027] In a third aspect, the present invention provides a recombinant host cell comprising a metabolic pathway for producing jasmonic acid, wherein the host cell overexpresses a gene encoding a polypeptide having 12-oxophytodienoate reductase (OPR) activity relative to a corresponding parent host cell, wherein the gene comprises a polynucleotide sequence having at least 90% identity to the polynucleotide sequence shown in SEQ ID NO: 2.

[0028] In a fourth aspect, provided herein is a biosynthetic method for producing jasmonic acid, the method comprising: culturing the recombinant cell of the third aspect above; and recovering jasmonic acid from at least one of the recombinant cell and a culture medium.

[0029] In the fifth aspect, the present invention provides a biosynthetic method for producing a polypeptide having 12-oxophytodienoate reductase (OPR) activity, the method comprising: culturing the recombinant cell of the third aspect above; and recovering the polypeptide having 12-oxophytodienoate reductase (OPR) activity from at least one of the recombinant cell and the culture medium.

[0030] Although the present disclosure is susceptible to various modifications and alternative forms, specific embodiments thereof are shown by way of example in the drawings and will be described in detail herein. However, it should be understood that the drawings and detailed description presented herein are not intended to limit the present disclosure to the specific embodiments disclosed, but on the contrary, the intent is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the present disclosure as defined by the appended claims.

[0031] Other features and advantages of the present invention will become apparent from the following detailed description of preferred embodiments of the invention with reference to the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] [ Figure 1 ] Figure 1 A shows the purification of g5119 protein on a Ni-NTA column. Figure 1 B shows g5119 protein purification on SDS-PAGE gel.

[0034] [ Figure 2 ] Figure 2 A typical HPLC profile of a reaction catalyzed by g5119 is included.

[0035] [ Figure 3 ] Figure 3Included is LC / MS analysis of the reaction catalyzed by g5119.

[0036] [ Figure 4 ] Figure 4 The jasmonic acid biosynthetic pathway in higher plants is shown.

[0037] [ Figure 5 ] Figure 5 Schematic diagram of cassette hph-gs5119 cloning in the gateway destination binary vector pPm43GW.

[0038] Implementation Description

[0039] definition:

[0040] As used herein, the singular form "a," "an," and "the" include plural referents unless the content clearly dictates otherwise.

[0041] To the extent that the terms "including," "having," and the like are used in the specification or claims, such terms are intended to be inclusive in a manner similar to the term "comprising" as interpreted when "comprising" is used as a transitional word in a claim.

[0042] The word “exemplary” is used herein to mean “serving as an example, instance, or illustration.” Any implementation described herein as “exemplary” is not necessarily to be construed as preferred or advantageous over other implementations.

[0043] A "cell system" is any cell that provides for the expression of an ectopic protein. It includes bacteria, yeast, filamentous fungi, plant cells, and animal cells. It includes both prokaryotic and eukaryotic cells. It also includes in vitro expression of proteins based on cellular components such as ribosomes.

[0044] "Coding sequence" should be given its ordinary and customary meaning to those of ordinary skill in the art, and is used without limitation to refer to a DNA sequence that encodes a specific amino acid sequence.

[0045] "Growing a cell system". Growth includes providing an appropriate culture medium that allows the cells to multiply and divide. It also includes providing resources so that the cells or cell components can translate and produce recombinant protein.

[0046] "Protein expression". Protein production can occur after gene expression. It consists of the stage after DNA has been transcribed into messenger RNA (mRNA). Then, mRNA is translated into polypeptide chains, which are ultimately folded into proteins. DNA can be present in cells through transfection - a process in which nucleic acids are intentionally introduced into cells. This term is often used for non-viral methods in eukaryotic cells. It can also refer to other methods and cell types, although other terms are preferred: "transformation" is more commonly used to describe non-viral DNA transfer in bacteria, non-animal eukaryotic cells, including plant cells. In animal cells, transfection is the preferred term because transformation is also used to refer to the progression to a cancerous state (carcinogenesis) in these cells. Transduction is often used to describe viral-mediated DNA transfer. Transformation, transduction, and viral infection are all included in the definition of transfection in this application.

[0047] According to the present disclosure, "filamentous fungi" or "molds" are eukaryotic microorganisms classified as members of the kingdom Fungi. Filamentous fungi typically grow in the form of multicellular filaments called hyphae. In contrast, fungi that can adopt a unicellular growth habit are referred to as "yeasts." Yeasts are unicellular organisms that evolved from multicellular ancestors. Yeast species that can be used in the present disclosure include, but are not limited to, those yeast species that have the ability to develop multicellular properties by forming strings of connected budding cells called pseudohyphae or pseudohyphae.

[0048] The term "complementary" should be given its usual and customary meaning to those of ordinary skill in the art and is used without limitation to describe the relationship between nucleotide bases that are capable of hybridizing to each other. For example, with respect to DNA, adenosine is complementary to thymine and cytosine is complementary to guanine. Accordingly, the subject technology also includes isolated nucleic acid fragments that are complementary to the complete sequences reported in the accompanying sequence listing as well as those substantially similar nucleic acid sequences.

[0049] The terms "nucleic acid" and "nucleotide" shall be given their usual and customary meanings to those of ordinary skill in the art, respectively, and are used without limitation to refer to deoxyribonucleotides or ribonucleotides and polymers thereof in either single-stranded or double-stranded form. Unless specifically limited, the term encompasses nucleic acids containing known analogs of natural nucleotides that have similar binding properties as the reference nucleic acid and are metabolized in a manner similar to naturally occurring nucleotides.

[0050] As used herein, the term "nucleotide sequence" refers to a heteropolymer of nucleotides or a sequence of these nucleotides from the 5' end to the 3' end of a nucleic acid molecule, and includes DNA or RNA molecules, including cDNA, DNA fragments or parts, genomic DNA, synthetic, for example, chemically synthesized DNA, plasmid DNA, mRNA and antisense RNA, any of which can be single-stranded or double-stranded. The terms "nucleotide sequence", "nucleic acid", "nucleic acid molecules", "oligonucleotides" and "polynucleotides" are also used interchangeably herein to refer to a heteropolymer of nucleotides. Nucleic acid molecules and / or nucleotide sequences provided herein are presented in 5' to 3' directions from left to right herein, and are represented by the standard code representing nucleotide characters as shown in U.S. sequence rules 37CFR §§1.821-1.825 and World Intellectual Property Organization (WIPO) standard ST.25. Unless otherwise indicated, a specific nucleic acid sequence also implicitly encompasses its conservative modifications or degenerate variants (e.g., degenerate codon substitutions) and complementary sequences, as well as sequences explicitly indicated.

[0051] As used herein, the term "gene" refers to a nucleic acid molecule that can be used to produce mRNA, antisense RNA, miRNA, anti-microRNA antisense oligodeoxyribonucleotides (AMOs) and the like. A gene may or may not be used to produce a functional protein or gene product. A gene may include both coding and non-coding regions, such as introns, regulatory elements, promoters, enhancers, terminator sequences and / or 5' and 3' untranslated regions. A gene can be "isolated," which means that nucleic acid is substantially or substantially free of components that are usually found to be associated with nucleic acid in its native state. Such components include other cell materials, various chemicals used in culture medium and / or chemically synthesized nucleic acids from recombinant production.

[0052] A gene in the form of "codon optimization" refers to an exogenous gene introduced into a cell, wherein the codons of the gene have been optimized for a specific cell. Typically, not all tRNAs are expressed equally or at the same level across species. Codon optimization of a gene sequence thus involves changing codons to match the most common tRNA, that is, codons recognized by low-prevalence tRNAs are changed to synonymous codons recognized by relatively more common tRNAs in a given fungal cell. In this way, mRNA from a codon-optimized gene will be more efficiently translated. Codons and synonymous codons preferably encode identical amino acids.

[0053] As used herein, "genetic modification" or "genetically modified" relates to such genetic modification of the genome of a fungal cell, such as yeast, and / or the introduction of exogenous nucleotide sequences, such as in the form of one or more plasmids, into a fungal cell, such as yeast.

[0054] The term "isolated" should be given its usual and customary meaning to those of ordinary skill in the art, and when used in the context of an isolated nucleic acid or isolated polypeptide, is used without limitation to refer to a nucleic acid or polypeptide that is present outside of its natural environment by the hand of man, and is therefore not a product of nature. An isolated nucleic acid or polypeptide may exist in a purified form, or may exist in a non-natural environment, such as a transgenic host cell.

[0055] As used herein, the terms "incubating" and "incubation" mean the process of mixing two or more chemical or biological entities (eg, a chemical compound and an enzyme) and allowing them to interact under conditions favorable to the production of a composition comprising a jasmonic compound.

[0056] The term "degenerate variant" refers to a nucleic acid sequence having a sequence of residues that differs from a reference nucleic acid sequence by one or more degenerate codon substitutions. Degenerate codon substitutions can be achieved by generating sequences in which the third position of one or more selected (or all) codons is replaced by mixed bases and / or deoxyinosine residues. A nucleic acid sequence and all its degenerate variants will express the same amino acid or polypeptide.

[0057] The terms "polypeptide", "protein" and "peptide" should be given their usual and customary meanings to those of ordinary skill in the art, respectively; these three terms are sometimes used interchangeably and are used without restriction to refer to amino acid polymers or amino acid analogs, regardless of their size or function. Although "protein" is often used in reference to relatively large polypeptides, and "peptide" is often used in reference to small polypeptides, the usage of these terms in the art overlaps and varies. Unless otherwise indicated, as used herein, the term "polypeptide" refers to peptides, polypeptides and proteins. When referring to polynucleotide products, the terms "protein", "polypeptide" and "peptide" are used interchangeably herein. Therefore, exemplary polypeptides include polynucleotide products, naturally occurring proteins, homologues, orthologues, paralogues, fragments, and other equivalents, variants and analogs of the aforementioned.

[0058] When used in reference to a reference polypeptide, the terms "polypeptide fragment" and "fragment" should be given their usual and customary meaning to those of ordinary skill in the art, and are used without limitation to refer to polypeptides in which amino acid residues are deleted compared to the reference polypeptide itself, but in which the remaining amino acid sequence is generally identical to the corresponding positions in the reference polypeptide. Such deletions may occur at the amino terminus or carboxyl terminus of the reference polypeptide, or alternatively at both termini.

[0059] The term "functional fragment" of a polypeptide or protein refers to a peptide fragment that is a portion of the full-length polypeptide or protein and has substantially the same biological activity as the full-length polypeptide or protein, or performs substantially the same function as the full-length polypeptide or protein (e.g., performs the same enzymatic reaction).

[0060] The terms "variant polypeptide", "modified amino acid sequence" or "modified polypeptide", which are used interchangeably, refer to an amino acid sequence that differs from a reference polypeptide by one or more amino acids, such as one or more amino acid substitutions, deletions and / or additions. In one aspect, the variant is a "functional variant" that retains some or all of the capabilities of the reference polypeptide.

[0061] The term "functional variant" further includes conservatively substituted variants. The term "conservatively substituted variant" refers to a peptide having an amino acid sequence that differs from a reference peptide in one or more conservative amino substitutions and maintains some or all of the activity of the reference peptide. "Conservative amino acid substitution" is the replacement of an amino acid residue with a functionally similar residue. Examples of conservative substitutions include replacing one non-polar (hydrophobic) residue such as isoleucine, valine, leucine or methionine with another; replacing another with a charged or polar (hydrophilic) residue, such as between arginine and lysine, between glutamine and asparagine, between threonine and serine; replacing another with a basic residue such as lysine or arginine; or replacing another with an acidic residue such as aspartic acid or glutamic acid; or replacing another with an aromatic residue such as phenylalanine, tyrosine or tryptophan. Such substitutions are expected to have little or no effect on the apparent molecular weight or isoelectric point of a protein or polypeptide. The phrase "conservatively substituted variants" also includes peptides in which residues are replaced with chemically derivatized residues, provided that the resulting peptide retains some or all of the activity of the reference peptide as described herein.

[0062] The term "variant" in conjunction with the polypeptides of the subject technology further includes functionally active polypeptides having an amino acid sequence that is at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or even 100% identical to the amino acid sequence of the reference polypeptide.

[0063] The term "homologous" in all its grammatical forms and spelling variants refers to the relationship between polynucleotides or polypeptides having a "common evolutionary origin", including polynucleotides or polypeptides from superfamilies and homologous polynucleotides or proteins from different species (Reeck et al., CELL 50:667, 1987). Such polynucleotides or polypeptides have sequence homology, as reflected by their sequence similarity, whether in terms of percentage identity or the presence of specific amino acids or motifs at conserved positions. For example, two homologous polypeptides can have amino acid sequences that are at least 75%, at least 76%, at least 77%, at least 78%, at least 79%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or even 100% identical.

[0064] "Suitable regulatory sequences" should be given their usual and customary meaning to those of ordinary skill in the art, and are used without limitation to refer to nucleotide sequences that are located upstream (5' non-coding sequences), internal or downstream (3' non-coding sequences) of a coding sequence and that influence the transcription, RNA processing or stability, or translation of the associated coding sequence. Regulatory sequences may include promoters, translation leader sequences, introns, and polyadenylation recognition sequences.

[0065] "Promoter" should be given its usual and customary meaning for those of ordinary skill in the art, and is used without restriction to refer to a DNA sequence that can control the expression of a coding sequence or functional RNA. Typically, the coding sequence is located 3' of the promoter sequence. The promoter can be derived from a natural gene as a whole, or it can be composed of different elements derived from different promoters found in nature, or even contain synthetic DNA segments. It will be appreciated by those skilled in the art that different promoters can guide the expression of genes in different tissues or cell types, or at different developmental stages or in response to different environmental conditions. Promoters that cause genes to be expressed in most cell types at most times are generally referred to as "constitutive promoters". It is further recognized that, since in most cases the exact boundaries of regulatory sequences are not yet fully defined, DNA fragments of different lengths may have the same promoter activity.

[0066] The term "operably linked" refers to the association of nucleic acid sequences on a single nucleic acid fragment such that the function of one nucleic acid sequence is affected by another nucleic acid sequence. For example, a promoter is operably linked to a coding sequence when the promoter can affect the expression of the coding sequence (i.e., the coding sequence is under the transcriptional control of the promoter). A coding sequence can be operably linked to a regulatory sequence in a sense or antisense orientation.

[0067] As used herein, the term "expression" should be given its ordinary and customary meaning to those of ordinary skill in the art, and is used without limitation to refer to the transcription and stable accumulation of sense (mRNA) or antisense RNA derived from nucleic acid fragments of the subject technology.

[0068] As used herein, the term "overexpress", "overexpresses" or "overexpression" refers to a higher level of gene activity, such as gene transcription, compared to a cell in its native state or, for example, a control that has not been transformed with a specific heterologous or recombinant polypeptide in an overexpressed state; a higher level of mRNA translation into protein; and / or a higher level of gene product, such as polypeptide production. A typical example of an overexpressed gene is a gene under the transcriptional control of another promoter compared to the native promoter of the gene. Additionally or alternatively, other changes in gene control elements, such as enhancers, can be used to overexpress a specific gene. In addition, modifications that affect, i.e., increase the translation of mRNA transcribed from a gene can be used alternatively or additionally to achieve overexpressed genes as used herein. These terms can also refer to an increase in the number of gene copies in a cell and / or an increase in the amount of mRNA and / or gene products. Overexpression can result in 25%, 50%, 100%, 200%, 500%, 1000%, 2000% or higher levels in a cell compared to a control level.

[0069] "Transformation" should be given its usual and customary meaning to those of ordinary skill in the art, and is used without limitation to refer to the transfer of a polynucleotide into a target cell. The transferred polynucleotide may be incorporated into the genome or chromosomal DNA of the target cell, resulting in genetically stable inheritance, or it may replicate independently of the host chromosome. A host organism containing the transformed nucleic acid fragment is referred to as "transgenic" or "transformed."

[0070] When used in conjunction with a host cell herein, the terms "transformed," "transgenic," and "recombinant" should be given their usual and customary meanings to those of ordinary skill in the art, respectively, and are used without limitation to refer to cells of a host organism, such as a plant or microbial cell, into which a heterologous nucleic acid molecule has been introduced. The nucleic acid molecule can be stably integrated into the genome of the host cell, or the nucleic acid molecule can exist as an extrachromosomal molecule. Such extrachromosomal molecules can be self-replicating. A transformed cell, tissue, or subject should be understood to encompass not only the final product of the transformation process, but also its transgenic progeny.

[0071] The terms "recombinant," "heterologous," and "exogenous," when used herein in conjunction with polynucleotides, should be given their usual and customary meanings to those of ordinary skill in the art, and are used without limitation to refer to polynucleotides (e.g., DNA sequences or genes) that are derived from a source foreign to the particular host cell, or, if from the same source, are modified from their original form. Thus, a heterologous gene in a host cell includes a gene that is endogenous to the particular host cell but has been modified, for example, by the use of site-directed mutagenesis or other recombinant techniques. These terms also include non-naturally occurring multiple copies of a naturally occurring DNA sequence. Thus, these terms refer to a DNA segment that is foreign or heterologous to the cell, or homologous to the cell, but is in a position or form within the host cell where the element is not normally found.

[0072] Similarly, the terms "recombinant," "heterologous," and "exogenous," when used herein in conjunction with a polypeptide or amino acid sequence, mean a polypeptide or amino acid sequence that is derived from a source foreign to the particular host cell, or, if from the same source, is modified from its original form. Thus, a recombinant DNA segment can be expressed in a host cell to produce a recombinant polypeptide.

[0073] "Endogenous," "native," or "wild-type" nucleic acid, nucleotide sequence, polypeptide, or amino acid sequence refers to a naturally occurring or endogenous nucleic acid, nucleotide sequence, polypeptide, or amino acid sequence. Thus, for example, "wild-type mRNA" is an mRNA that is naturally present in or endogenous to an organism. A "homologous" nucleic acid sequence is a nucleotide sequence naturally associated with a host cell into which it is introduced.

[0074] The terms "plasmid", "vector" and "cassette" should be given their usual and customary meanings to those of ordinary skill in the art, respectively, and are used without restriction to refer to extrachromosomal elements that often carry genes, are not part of the central metabolism of the cell, and are usually in the form of circular double-stranded DNA molecules. Such elements can be self-replicating sequences, genome integration sequences, phages or nucleotide sequences derived from linear or circular, single-stranded or double-stranded DNA or RNA from any source, many of which have been connected or reorganized into unique structures that can introduce promoter fragments and DNA sequences of selected gene products into cells together with appropriate 3' non-translated sequences. "Transformation cassette" refers to a specific vector that contains foreign genes and, in addition to foreign genes, has elements that promote transformation of specific host cells. "Expression cassette" refers to a specific vector that contains foreign genes and, in addition to foreign genes, has elements that allow enhanced expression of the gene in a foreign host.

[0075] As used herein, the term "increased copy number" means that there is at least one additional copy of at least a polypeptide coding sequence of a given gene in a recombinant cell compared to the number of copies of the same gene in a parent cell, such as a wild-type cell, from which the recombinant cell is derived. For example, the recombinant cell may contain 1, 2, 3, 4, 5, 10 or more additional copies of at least a polypeptide coding sequence of a given gene relative to the number of copies of the same gene in the parent cell. The additional copies of a given gene may be integrated into the genome of the recombinant cell, or may be present on one or more autonomously replicating vectors or plasmids present in the recombinant cell.

[0076] As used herein, the term "sequence identity" refers to the degree to which two optimally aligned polynucleotide or peptide sequences remain constant throughout the alignment window in terms of components, such as nucleotides or amino acids. An "identity score" for an aligned segment of a test sequence and a reference sequence is the number of identical components shared by the two aligned sequences divided by the total number of components in the reference sequence segment (i.e., the entire reference sequence or a smaller defined portion of a reference sequence).

[0077] As used herein, the term "percent sequence identity" or "percent identity" refers to the percentage of identical nucleotides in the linear polynucleotide sequence of a reference ("query") polynucleotide molecule (or its complementary strand) compared to a test ("subject") polynucleotide molecule (or its complementary strand) when the two sequences are optimally aligned (wherein appropriate nucleotide insertions, deletions or gaps total less than 20% of the reference sequence within the comparison window). The optimal alignment of sequences for aligning the comparison window is well known to those skilled in the art and can be performed by tools such as the local homology algorithm of Smith and Waterman, the homology alignment algorithm of Needleman and Wunsch, the similarity search method of Pearson and Lipman, and preferably by computerized implementations of these algorithms such as GAP, BESTFIT, FASTA and TFASTA available as part of the GCG (registered trademark) Wisconsin Package (registered trademark) (Accelrys Inc., Burlington, MA). The "identity score" for the comparison segment of a test sequence and a reference sequence is the number of identical components shared by the two comparison sequences divided by the total number of components in the reference sequence segment (i.e., the entire reference sequence or a smaller limited portion of the reference sequence). Percent sequence identity is expressed as the identity score multiplied by 100. The comparison of one or more polynucleotide sequences can be for a full-length polynucleotide sequence or a portion thereof, or a longer polynucleotide sequence. For the purposes of the present disclosure, "percent identity" can also be determined for translated nucleotide sequences using BLASTX version 2.0, and for polynucleotide sequences using BLASTN version 2.0.

[0078] The percent sequence identity is preferably determined using the "Best Fit" or "Gap" program of the Sequence Analysis Software Package (trademark) (Version 10; Genetics Computer Group, Inc., Madison, WI). "Gap" uses the algorithm of Needleman and Wunsch (Needleman and Wunsch, JOURNAL OF MOLECULARBIOLOGY 48:443-453, 1970) to find the alignment of two sequences that maximizes the number of matches and minimizes the number of gaps. "BestFit" uses the local homology algorithm of Smith and Waterman (Smith and Waterman, ADVANCES IN APPLIED MATHEMATICS, 2:482-489, 1981, Smith et al., NUCLEIC ACIDS RESEARCH 11:2205-2220, 1983) to perform optimal alignment of the best segment of similarity between two sequences, and inserts gaps to maximize the number of matches. Percent identity is most preferably determined using the "Best Fit" program.

[0079] Useful methods for determining sequence identity are also disclosed in the Basic Local Alignment Search Tool (BLAST) program, which is publicly available from the National Center Biotechnology Information (NCBI) at the National Library of Medicine, National Institute of Health, Bethesda, Md. 20894; see BLAST Manual, Altschul et al., NCBI, NLM, NIH; Altschul et al., J. MOL. BIOL. 215:403-410 (1990); version 2.0 or higher of the BLAST program allows gaps (deletions and insertions) to be introduced into the alignment; for peptide sequences, BLASTX can be used to determine sequence identity; and for polynucleotide sequences, BLASTN can be used to determine sequence identity.

[0080] As used herein, the term "substantial percentage sequence identity" refers to a percentage sequence identity of at least about 70% sequence identity, at least about 80% sequence identity, at least about 85% sequence identity, at least about 90% sequence identity, or even greater sequence identity, such as about 98% or about 99% sequence identity. Therefore, one embodiment of the present invention is a polynucleotide molecule having at least about 70% sequence identity, at least about 80% sequence identity, at least about 85% sequence identity, at least about 90% sequence identity, or even greater sequence identity, such as about 98% or about 99% sequence identity, with the polynucleotide sequences described herein. Polynucleotide molecules encoding proteins having the activity of the gs5119 sequence of the present disclosure are capable of directing the production of various jasmonic acid compounds and have a large percentage sequence identity with the polynucleotide sequences provided herein, and are encompassed within the scope of the present disclosure.

[0081] As used herein, the term "identity" is the score of identical amino acids between a pair of sequences after sequence alignment (which can be done using only sequence information or structural information or some other information, but typically it is based on sequence information alone), and the term "similarity" refers to a score assigned based on an alignment using some similarity matrix. The similarity index can be any of the following BLOSUM62, PAM250 or GONNET, or any matrix used by those skilled in the art for sequence alignment of proteins.

[0082] Identity is the degree of correspondence between two subsequences (without gaps between the sequences). An identity of 25% or more implies functional similarity, while 18-25% implies structural or functional similarity. It should be remembered that two completely unrelated or random sequences (which are greater than 100 residues) can have an identity higher than 20%. Similarity is the degree of similarity between two sequences when they are compared. This is determined by their identity.

[0083] As is apparent from this specification, certain aspects of the present disclosure are not limited to the specific details of the examples shown herein, and it is therefore contemplated that other modifications and applications or their equivalents will occur to those skilled in the art. Accordingly, it is contemplated that the claims should cover all such modifications and applications that do not depart from the spirit and scope of the present disclosure.

[0084] In addition, unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the present disclosure belongs. Although preferred methods and materials are described above, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present disclosure.

[0085] Metabolically engineered cells for jasmonic acid biosynthesis:

[0086] In one aspect, the disclosure provides a host cell having an efficient metabolic pathway including at least one enzymatic activity. The pathway produces 12-oxophytodienoic acid (12-OPDA), which is then reduced to 3-oxo-2-(cis-2'-pentenyl)-cyclopentane-1-octanoic acid (OPC8). Such cells may be naturally occurring, but in certain embodiments are recombinant cells produced by genetic engineering.

[0087] In representative embodiments, OPC8 is produced in a reaction in which endogenous 12-OPDA is a substrate, and the reaction is catalyzed by a polypeptide having OPR activity. The polypeptide may be a "gs5119-like protein" (or "gs5119 protein" or "gs5119") comprising an amino acid sequence as shown in SEQ ID NO: 1, or a variant thereof having OPR activity and comprising an amino acid sequence having at least 90% (e.g., at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100%) identity to SEQ ID NO: 1. In various aspects of these embodiments, the variant polypeptide has the same or substantially the same OPR activity as the gs5119 described herein, e.g., an enzyme comprising the amino acid sequence of SEQ ID NO: 1.

[0088] The polypeptide with OPR activity is overexpressed relative to the corresponding parent host cell derived from it of the recombinant host cell. In some embodiments, overexpression can be achieved by genetically modifying the host cell to include one or more ectopic copies of the natural gene encoding the polypeptide with OPR activity. In a further non-exclusive embodiment, the polypeptide with OPR activity is overexpressed by replacing the natural promoter of the gene expressing the polypeptide with OPR activity with a promoter with a higher expression level than the promoter natural to the host cell. Exemplary higher level promoters include ToxA and ToxB from Pyrenophora tritici-repentis, although any suitable promoter for high-level recombinant expression in fungal host cells can play this role. Alternatively or in combination with the aforementioned method, the overexpression of the polypeptide with OPR activity can be achieved by introducing at least one copy of an exogenous polynucleotide sequence into the host cell, and the exogenous polynucleotide sequence is not natural to the host cell and encodes a polypeptide with OPR activity.

[0089] The nucleic acid encoding the polypeptide having OPR activity may include a polynucleotide sequence encoding a gs5119-like polypeptide. The polynucleotide sequence, also referred to as a "gs5119 encoding polynucleotide" or a "gs5119 polynucleotide", may be, for example, a sequence as shown in SEQ ID NO:2 or a variant thereof, such as a codon-optimized sequence as shown in SEQ ID NO:3. Therefore, in many embodiments, the present disclosure provides a nucleic acid comprising a nucleotide sequence having at least 90% (e.g., at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100%) identity to SEQ ID NO:2. Also provided are nucleic acids comprising a nucleotide sequence having at least 90% (e.g., at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) identity to SEQ ID NO: 3. In some embodiments, the nucleotide sequence encodes a polypeptide comprising the enzyme gs5119, i.e., an enzyme comprising the amino acid sequence of SEQ ID NO: 1.

[0090] In certain embodiments of this aspect, the host cell can be a bacterium. Typical bacterial genera include: Escherichia; Salmonella; Bacillus; Acinetobacter; Corynebacterium; Methylosinus; Methylomonas; Rhodococcus; Pseudomonas; Rhodobacter; r); Synechocystis; Aspergillus; Arthrobotlys; Brevibacteria; Microbacterium; Arthrobacter; Citrobacter; Klebsiella; Pantoea; Salmonella; Corynebacterium and Clostridium.

[0091] In a further embodiment, the host cell is a eukaryotic cell selected from the group consisting of a yeast cell, a filamentous fungal cell, a plant cell, and an animal cell.

[0092] One aspect of the embodiment relates to a genetically modified filamentous fungal cell capable of producing jasmonate. Typical fungal cells include species of the following genera: Lasiodiplodia, Rhizopus, Fusidium, Gibberella, Trichoderma, Hypocrea, Aspergillus, Fusarium, Penicillium, Neurospora, Chaetomium, Acremonium , Glomerella, Myceliophthora, Sporotrichum, Thielavia, Chrysosporium, Corynascus, Ctenomyces, Verticillium, Cordyceps, Nectria, and Magnaporthe, including their asexual and sexual forms and recognized synonymous genera.

[0093] The phrase "fungal species belonging to the genus Lactodispora" may mean that the fungus is classified as Lactodispora according to the taxonomy known to those skilled in the art of mycology. In particular, those classified into the Lactodispora group according to the taxonomy used by the NCBI (National Center for Biotechnology Information) database (www.ncbi.nlm.nih.gov / Taxonomy / Browser / wwwtax.cgi) may be used. Examples of fungi belonging to the genus Lasiodiplodia include, but are not limited to, Lasiodiplodia abnormis, Lasiodiplodia citri, Lasiodiplodia citricola, Lasiodiplodia crassispora, Lasiodiplodia fiorii, Lasiodiplodia frezaliana, Lasiodiplodia gilanensis, Lasiodiplodia gonubiensis, Lasiodiplodia hormozganensis, Lasiodiplodia iraniensis, Lasiodiplodia margaritacea, Lasiodiplodia missouriana, Lasiodiplodia paraphysaria, Lasiodiplodia parva, Lasiodiplodia plurivora, Lasiodiplodia pseudotheobromae, Lasiodiplodia ricini, Lasiodiplodia rubropurpurea, Lasiodiplodia thomasiana, Lasiodiplodia undulata, Lasiodiplodia venezuelensis, Lasiodiplodia viticola.Fungal species belonging to other genera include, but are not limited to, T. reesei, H. jecorina, A. niger, A. fumigatus, A. orzyae, A. nidulans, F. oxysporum, N. crassa, C. thermophilum, A. thermophilum, G. graminicola, M. thermophila, S. thermophile, T. terrestris, T. heterothallica, C. thermophile, V. dahlia, C. militaris, N. heamatococca, or M. orzyae.

[0094] In another aspect of the embodiment, the host cell is a cell isolated from a plant selected from the group consisting of soybean; rapeseed; sunflower; cotton; corn; tobacco; alfalfa; wheat; barley; oats; sorghum; rice; broccoli; cauliflower; cabbage; parsnips; melons; carrots; celery; parsley; tomatoes; potatoes; strawberries; peanuts; grapes; grass seed crops; sugar beets; sugar cane; beans; peas; rye; flax; hardwood trees; softwood trees; forage grasses; Arabidopsis thaliana; rice (Oryza sativa); barley (Hordeum yulgare); switchgrass (Panicum vigratum); Brachypodium spp.; Brassica spp.; and Crambea byssinic.

[0095] In some embodiments, the host cell is genetically modified to overexpress a polypeptide having OPR activity relative to a parent, unmodified cell, such as a wild-type host cell, wherein the polypeptide comprises an amino acid sequence having at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or even 100% identity to the amino acid sequence as shown in SEQ ID NO: 1. The protein with OPR-like protein can be homologous or heterologous with respect to the host cell. For the purposes of this article, in certain embodiments, the homologous polypeptide with OPR activity is encoded by a polynucleotide sequence that naturally occurs in, or is separated from or derived from, a taxonomic species that is the same or taxonomically equivalent to the host cell. In addition, as recognized by those skilled in the art, homologous proteins can contain one or more insertions, deletions, and substitutions and are still considered to be "derived from" the same species as the wild-type host cell. Such one or more insertions, deletions, and substitutions may result in an increase or decrease in the expression or activity of the homologous polypeptide. Similarly, a polynucleotide encoding a homologous polypeptide having OPR activity may contain one or more insertions, deletions, and substitutions (including substitutions that optimize codon usage without altering the sequence of the encoded protein).

[0096] A heterologous polypeptide with OPR activity is encoded by a polynucleotide sequence that is naturally present in, or separated from or derived from, a taxonomic species different from the host cell. In addition, as recognized by those skilled in the art, a heterologous polypeptide with OPR activity may contain one or more insertions, deletions, and substitutions and still be considered to be "derived from" a taxonomic species different from the host cell. Such one or more insertions, deletions, and substitutions may result in an increase or decrease in the expression or activity of a heterologous polypeptide with OPR activity. Similarly, a polynucleotide encoding a heterologous polypeptide with OPR activity may contain one or more insertions, deletions, and substitutions (including substitutions that optimize codon usage without changing the sequence of the encoded protein).

[0097] As used herein, with respect to polynucleotide sequences, "derived from" refers to the isolation of a target polynucleotide sequence using one or more molecular biology techniques known to those skilled in the art, including but not limited to reverse translation of polypeptide or amino acid sequences, cloning, subcloning, amplification by PCR, in vitro synthesis, and the like. In addition, as recognized by those skilled in the art, a polynucleotide sequence derived from a target polynucleotide sequence may be modified by one or more insertions, deletions, and substitutions and still be considered "derived from" the target nucleotide sequence. Such one or more insertions, deletions, and substitutions may result in an increase or decrease in the expression or activity of a protein of interest encoded by the polynucleotide sequence, and may be located within a promoter sequence, a 5' or 3' untranslated region, or within the coding region of a protein of interest.

[0098] As used herein with respect to polynucleotide sequences, "isolated" or "isolated" means altered from its natural state by separating the nucleic acid sequence from some or all of the naturally occurring nucleic acid sequences with which it is associated in nature.

[0099] In some embodiments, the host cell can be genetically modified by transforming the host cell with the gs5119 genetic construct. As used herein, a "gs5119 genetic construct" refers to an isolated polynucleotide comprising elements necessary for increasing the expression of a gs5119-like protein. These elements may include, but are not limited to, a polynucleotide sequence encoding a gs5119-like protein (coding sequence), a promoter operably linked to the coding sequence and comprising a polynucleotide sequence that directs transcription and translation of the coding sequence.

[0100] The recombinant host cell of the present invention may further comprise one or more genetic constructs, which instruct the production and secretion of one or more homologous or heterologous polypeptides with OPR activity, such as gs5119 or gs5119-like proteins. Such constructs comprise polynucleotide elements, including but not limited to the coding sequence of polypeptides, a promoter operably connected to the coding sequence and comprising a polynucleotide sequence for instructing the transcription of the coding region, and a sequence encoding a secretion signal peptide operably connected to the coding sequence, and a targeting polynucleotide sequence for instructing the homologous recombination of the construct into the genome of the host cell. The terms "secretion signal peptide", "secretion signal" and "signal peptide" refer to any nucleotide and / or amino acid sequence that may be involved in the secretion of a mature or precursor form of a secretory protein. The signal sequence may be endogenous or exogenous with respect to the host cell. The signal sequence may be a signal sequence that is generally associated with a protein of interest or a gene encoding another secretory protein. The signal sequence may also be a "hybrid signal sequence" containing a partial sequence from two or more genes encoding a secretory protein.

[0101] As understood by those of ordinary skill in the art, coding sequence, promoter and / or secretion signal can be derived from parent host cell, different organisms and / or synthesized in vitro.For example, promoter and secretion signal can be derived from one or more genes of coded protein, for example, gene highly expressed in filamentous fungi usually, when parent host cell grows in fermentation process such as fermentation process defined below, described protein is highly expressed and secreted.These polynucleotide elements can also be changed or transformed by replacement, substitution, addition or elimination of one or more nucleic acids relative to naturally occurring polynucleotide.However, it should be understood that practice of the present invention is not limited to the selection of promoter in gs5119 genetic construct or the selection of promoter and secretion signal in the genetic construct expressing gs5119 sample enzyme.

[0102] The above genetic constructs may contain selectable markers for identifying transformed host cells. The selectable marker may be present on the genetic construct, or the selectable marker may be a separate isolated polynucleotide co-transformed with the genetic construct. The selection of selectable markers is well known to those skilled in the art and includes genes (synthetic or natural) that confer the ability of transformed cells to utilize metabolites that are not normally metabolized by microorganisms (e.g., the Aspergillus nidulans amdS gene encodes acetamidase and confers the ability to grow with acetamide as the sole nitrogen source) or antibiotic resistance (e.g., the Escherichia coli hph gene encodes hygromycin-β-phosphotransferase and confers resistance to hygromycin). Alternatively, if the host cell expresses little or no activity of the selected marker, the corresponding gene can be used as a marker. Examples of such markers include trp, pyr4, pyrG, argB, leu, etc. Therefore, the corresponding host strain must lack the functional gene corresponding to the selected marker, i.e., lack the expression of trp, pyr, arg, leu, etc.

[0103] The genetic construct may contain a transcription terminator that is functional in the host cell, as known to those skilled in the art. The transcription terminator may be located immediately downstream of the coding sequence. The practice of the present invention is not constrained by the selection of a transcription terminator that is sufficient to direct transcription termination in the host cell.

[0104] The genetic construct may contain additional polynucleotide sequences between the various sequence elements as described herein. These sequences, which may be natural or synthetic, may result in one or more amino acids being added to the protein encoded by the construct. The practice of the present invention is not constrained by the additional polynucleotide sequences present between the various sequence elements of the genetic construct present in the host cell.

[0105] As disclosed above, some embodiments relate to recombinant filamentous fungal host cells. The method by which genetic constructs are introduced into fungal cells is familiar to those skilled in the art, and includes but is not limited to Agrobacterium tumefaciens-mediated transformation, calcium chloride treatment of fungal protoplasts to weaken cell membrane, add polyethylene glycol to allow cell membrane fusion, depolarize cell membrane by electroporation, or shoot constructs through cell wall and membrane via microparticle bombardment with a particle gun. Practice of the present invention is not subject to the constraint of the method by which genetic constructs are introduced into fungal cells.

[0106] It is understood that recombinant fungal cells as presented herein encompass both the perfect state and the imperfect state, as well as other taxonomic equivalents, such as anamorphs and teleomorphs, regardless of the species name by which they are known. Further examples of taxonomic equivalents can be found, for example, in Cannon, Mycopathologica 111:75-83, 1990; Moustafa et al., Persoonia 14:173-175, 1990; Stalpers, Stud. Mycol. 24, 1984; Upadhyay et al., Mycopathologia 87:71-80, 1984; Guarro et al., Mycotaxon 23:419-427, 1985; Awao et al., Mycotaxon 16:436-440, 1983; von Klopotek, Arch. Microbiol. 98:365-369, 1974; and Long et al., 1994, ATCC Names of Industrial Fungi, ATCC, Rockville Md. Those skilled in the art will readily recognize the identity of appropriate equivalents. Accordingly, it should be understood that, unless otherwise indicated, use of a particular genus and / or species name in this disclosure also refers to genera and species that are related through asexual or sexual relationships, genera and species that are identified as synonyms, and those genera and species that have been or may in the future be reclassified into one of the claimed genera or species.

[0107] In plant cells, the expression vector of the subject technology can include a coding region operably linked to a promoter that can direct the expression of the recombinant polypeptide of the subject technology in the desired tissue at the desired developmental stage. For convenience, the polynucleotide to be expressed can include a promoter sequence and a translation leader sequence derived from the same polynucleotide. There should also be a 3' non-coding sequence encoding a transcription termination signal. The expression vector can also include one or more introns to promote polynucleotide expression.

[0108] For plant host cells, any combination of any promoter and any terminator that can induce coding region expression can be used in the vector sequence of the subject technology. Some suitable examples of promoters and terminators include those promoters and terminators from nopaline synthase (nos), octopine synthase (ocs) and cauliflower mosaic virus (CaMV) genes. A type of effective plant promoter that can be used is a high-level plant promoter. Such promoters that are operably connected to the expression vector of the subject technology should be able to promote the expression of the vector. The high-level plant promoter that can be used in the subject technology includes, for example, a promoter (Berry-Lowe et al., J.Molecular and App.Gen., 1:483 498 (1982), the entire contents of which are incorporated herein to the extent that it is consistent therewith) of the small subunit (ss) of ribulose-1,5-bisphosphate carboxylase from soybean, and the promoter of chlorophyll alb binding protein. Both promoters are known to be light-inducible in plant cells (see, e.g., Genetic Engineering of Plants, an Agricultural Perspective, A. Cashmore, Plenum, NY (1983), pp. 29-38; Coruzzi, G. et al., The Journal of Biological Chemistry, 258:1399 (1983), and Dunsmuir, P. et al., Journal of Molecular and Applied Genetics, 2:285 (1983), each of which is hereby incorporated by reference to the extent they are not inconsistent herewith).

[0109] Synthetic Biology

[0110] Standard recombinant DNA and molecular cloning techniques used herein are well known in the art and are described, for example, by Sambrook, J., Fritsch, EF, and Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd ed.; Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1989 (hereinafter "Maniatis"); and Silhavy, TJ, Bennan, ML, and Enquist, LW Experiments with Gene Fusions; Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1984; and Ausubel, FM et al., In Current Protocols in Molecular Biology, 1987, published by Greene Publishing and Wiley-Interscience; (the entire contents of each of said references are hereby incorporated herein by reference).

[0111] Production System

[0112] Protein expression in recombinant host cells is often carried out using vectors containing constitutive or inducible promoters that direct the expression of one or more recombinant proteins.

[0113] Fusion vectors add a number of amino acids to the protein encoded therein, typically to the amino terminus of the recombinant protein. Such fusion vectors typically serve three purposes: (1) increase the expression of the recombinant protein; (2) increase the solubility of the recombinant protein; and (3) aid in the purification of the recombinant protein by acting as a ligand in affinity purification. Typically, a proteolytic cleavage site is introduced at the junction of the fusion moiety and the recombinant protein to allow separation of the recombinant protein from the fusion moiety after purification of the fusion protein. Such vectors are within the scope of the present disclosure.

[0114] In one embodiment, the expression vector includes those genetic elements for expressing a recombinant polypeptide in a bacterial cell or other microorganism. Elements for transcription and translation in a microbial cell may include a promoter, a coding region of a protein complex, and a transcription terminator.

[0115] Those of ordinary skill in the art will be aware of molecular biology techniques that can be used to prepare expression vectors.As described above, polynucleotides for incorporation into expression vectors of the subject technology can be prepared by conventional techniques such as the polymerase chain reaction (PCR).

[0116] Several molecular biology techniques have been developed to operably link DNA to a vector via complementary cohesive ends. In one embodiment, complementary homopolymeric strands can be added to the nucleic acid molecule to be inserted into the vector DNA. The vector and nucleic acid molecule are then connected by hydrogen bonding between the complementary homopolymeric tails to form a recombinant DNA molecule.

[0117] In an alternative embodiment, the synthetic joint containing one or more restriction sites provided is used for the polynucleotide of the subject technology to be operably connected to an expression vector. In one embodiment, the polynucleotide is generated by restriction endonuclease digestion. In one case, with bacteriophage T4 DNA polymerase or Escherichia coli DNA polymerase I, nucleic acid molecules are processed, and the enzyme removes outstanding 3'-single-stranded end with its 3'-5'-exonuclease activity, and fills the recessed 3' end with its polymerization activity, thereby generates the flat-ended DNA segment. Then in the presence of the enzyme that can catalyze the connection of the flat-ended DNA molecule, for example bacteriophage T4 DNA ligase, the flat-ended segment is incubated with a large amount of molar excess joint molecules. Therefore, the reaction product is the polynucleotide that carries the polymerized joint sequence at its end. These polynucleotides are then cut with suitable restriction enzymes, and are connected to the expression vector that has been cut with the enzyme that produces the end compatible with the end of the polynucleotide.

[0118] Alternatively, a vector with a ligation-independent cloning (LIC) site may be employed. The desired PCR-amplified polynucleotide may then be cloned into the LIC vector without restriction digestion or ligation (Aslanidis and de Jong, Nucl. Acid. Res. 18 6069-74, (1990), Haun et al., Biotechniques 13, 515-18 (1992), which are incorporated herein by reference to the extent that it is consistent herewith).

[0119] In one embodiment, to isolate and / or modify the polynucleotide of interest for insertion into a selected plasmid, the use of PCR is appropriate. Appropriate primers for use in PCR preparation of the sequence can be designed to isolate the desired coding region of the nucleic acid molecule, add restriction endonuclease or LIC sites, and place the coding region in the desired reading frame.

[0120] In one embodiment, appropriate oligonucleotide primers are used to prepare polynucleotides for incorporation into the expression vector of the subject technology using PCR. The coding region is amplified, and the primers themselves become incorporated into the amplified sequence product. In one embodiment, the amplification primer contains a restriction endonuclease recognition site that allows the amplified sequence product to be cloned into an appropriate vector.

[0121] The expression vector can be introduced into a host cell, such as a bacterium or other microorganism such as a yeast or fungus, by conventional transformation or transfection techniques. The transformation of appropriate cells with the expression vector of the subject technology is accomplished by methods known in the art, and generally depends on both the type of the vector and the cell. Suitable techniques include calcium phosphate or calcium chloride coprecipitation, DEAE-dextran-mediated transfection, lipofection, chemical poration or electroporation.

[0122] Microbial host cell expression systems and expression vectors containing regulatory sequences for directing high-level expression of foreign proteins are well known to those skilled in the art. Any of these can be used to construct vectors for expressing the recombinant polypeptides of the subject technology in microbial host cells. These vectors can then be introduced into appropriate microorganisms via transformation to allow high-level expression of the recombinant polypeptides of the subject technology.

[0123] Vectors or boxes that can be used to transform suitable microbial host cells are well known in the art. Typically, the vector or box contains sequences that direct the transcription and translation of the relevant polynucleotides, selectable markers, and sequences that allow autonomous replication or chromosomal integration. Suitable vectors include a region 5' of the polynucleotide containing the transcription initiation control, and a region 3' of the DNA fragment that controls transcription termination. It is preferred that both control regions are derived from genes homologous to the transformed host cell, although it should be understood that such control regions do not need to be derived from genes native to the specific species selected as the host.

[0124] The initiation control region or promoter that can be used to drive the expression of recombinant polypeptides in the desired microbial host cell is numerous and familiar to those skilled in the art. In fact, any promoter capable of driving these genes is suitable for the subject technology, including but not limited to CYCI, HIS3, GALI, GALIO, ADHI, PGK, PH05, GAPDH, ADCI, TRPI, URA3, LEU2, ENO, TPI (can be used for expression in yeast (Saccharomyces)); AOXI (can be used for expression in Pichia (Pichia)); lac, trp, JPL, IPR, T7, tac and trc (can be used for expression in Escherichia coli (Escherichiacoli)); and ToxA and ToxB (can be used for expression in filamentous fungi).

[0125] Successfully transformed cells, i.e., those containing the expression vector, can be identified by techniques well known in the art. For example, cells transfected with an expression vector of the subject technology can be cultured to produce a polypeptide as described herein. Cells can be examined for the presence of expression vector DNA by techniques well known in the art. The transformed host cell can contain a single copy of the expression vector previously described, or alternatively, multiple copies of the expression vector.

[0126] Biosynthesis of jasmonate

[0127] In a further aspect, the present invention includes culturing a recombinant host cell comprising a metabolic pathway that produces jasmonic acid, wherein the host cell overexpresses a polypeptide having 12-oxophytodienoate reductase (OPR) activity relative to a corresponding parental host cell. The recombinant host cell can be cultured in a deep liquid fed-batch or continuous culture.

[0128] As used herein, the terms "cultivating" and "culturing" refer to growing a cell culture, such as a microbial cell colony, under suitable conditions in a liquid or solid medium. Cultivation can be carried out using conventional fermentation equipment (e.g., shake flasks, fermentors, and bioreactors) suitable for such purposes.

[0129] As defined herein, "submerged liquid culture" is a cell culture in which cells are suspended or substantially suspended in a liquid medium containing nutrients required to maintain cell viability. The culture is generally agitated at a sufficient rate to ensure distribution of the cells throughout the medium. The agitation rate is also typically selected to prevent the formation of concentration gradients of nutrients.

[0130] In a "batch process" or "batch fermentation", all necessary culture and media components, except oxygen for aerobic processes, are placed in a reactor at the start of the operation, and fermentation is allowed to proceed to completion, at which time product is withdrawn from the reactor.

[0131] In a "fed-batch process" or "fed-batch fermentation", the culture is fed continuously or sequentially with one or more medium components, without removing the culture fluid.

[0132] In a "continuous process" or "continuous fermentation", fresh medium is continuously supplied and culture fluid is removed at a rate that is equal or substantially equal in volume to maintain the culture at a steady growth rate. Referring to a continuous process, "steady state" refers to a state in which the concentration of reactants does not change significantly, and "quasi-steady state" refers to a state in which, after the reaction begins, the concentration of reactants fluctuates within a range consistent with the normal operation of a continuous hydrolysis process. A continuous fermentation process may also be referred to as a CSTR (continuous stirred tank reactor) fermentation. An example of a continuous fermentation process is a chemostat, in which the growth rate of a microorganism is controlled by the supply of a limiting nutrient in the culture medium.

[0133] In the fermentation process of the present invention, the recombinant host cells can be first cultured in a batch fermentation, usually containing a non-inducing carbon source. After the batch fermentation, which is usually identified by the exhaustion of substantially all available carbon sources, is completed, for example, when the carbon source concentration in the culture filtrate is no more than 1 g / L, the recombinant host cells are cultured in a fed-batch, continuous or a combination of fed-batch and continuous submerged liquid culture.

[0134] Fed-batch and continuous processes are usually carried out in one or more bioreactors. Typical bioreactors for cell culture fermentation processes include, but are not limited to, mechanically agitated vessels or those vessels with other agitation means (e.g., air injection). Bioreactors can be temperature and pH controlled. Typically, there are means for providing an in-situ cleaning reactor. It is also possible to provide means for disinfecting or sterilizing the bioreactor before the target organism is introduced so as to minimize or prevent carbon source competition from other organisms. Bioreactors can be constructed from a variety of materials, but the most common are glass or stainless steel. Provisions are generally made for sampling (in a manner that the introduction of undesirable competing organisms is prevented or minimized). Means for obtaining other measurements (e.g., ports and probes for measuring dissolved oxygen concentration or other solutes such as ammonium ion concentration) are often provided. The practice of the present invention is not limited by the selection of bioreactors.

[0135] In the fermentation process of the present invention, fed-batch, continuous or combined fed-batch and continuous deep liquid culture are provided with a feed solution containing a carbon source. In some embodiments, the carbon source is composed of one or more carbohydrates. As used herein, the term "carbon source" refers to a carbonaceous substance that provides the growth of a parent or recombinant cell culture and a major portion of carbon required for the production of jasmonates by a parent or recombinant cell culture. For purposes of this paper, the carbon source can be one or more carbohydrates, non-carbohydrate substances such as sugar alcohols, organic acids or alcohols or a combination thereof. However, for purposes of this paper, the organic nitrogen source that can be provided to a cell culture may or may not be considered as a carbon source.

[0136] In the fermentation process of the present invention, the feed solution may contain one or more additional components, such as nitrogen sources, vitamins, minerals and salts required for fungal cell growth as known to those skilled in the art. The nitrogen source can be inorganic and / or organic in nature, and includes but is not limited to one or more amino acids, peptides and proteins (e.g., corn steep liquor) in pure or raw form, any number of protein hydrolysates (peptone, tryptone, casamino acids), yeast extract, ammonium, ammonium hydroxide, ammonium salts, urea, nitrates and combinations thereof. The practice of the fermentation process of the present invention is not limited by the additional components of the feed solution.

[0137] The feed solution is provided to the fermentation process at a certain rate, the feed rate or "carbon addition rate" or "CAR" (measured as g carbon / liter / hour). In an exemplary fermentation process according to the present invention, the feed solution can be provided to the fed-batch culture at a carbon addition rate of about 0.2 to about 4 g carbon / L culture / h, or any rate therebetween, such as 0.2, 0.3, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0, 2.2, 2.5, 3.0, 3.5 and 4.0 g carbon / L culture / h, or any rate therebetween. Alternatively, the feed solution can be provided to the fed-batch culture at a rate of about 0.001 to 0.1 h -1 or any dilution rate therebetween, for example, at about 0.001, 0.005, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1 h -1 or any dilution rate in between for continuous cultures.

[0138] The fermentation process of the present invention can be carried out at a temperature of about 20°C to about 55°C or any temperature therebetween, for example, about 30°C to about 45°C or any temperature therebetween, or 20, 22, 25, 28, 30, 32, 35, 38, 40, 42, 45, 48, 50°C, 55°C or any temperature therebetween.

[0139] The fermentation process of the present invention can be carried out at a pH of about 2.5 to 8.5 or any pH therebetween, such as about pH 3.5 to pH 7.0 or any pH therebetween, such as about pH 2.5, 3.0, 3.2, 3.5, 3.8, 4.0, 4.2, 4.5, 4.8, 5.0, 5.2, 5.4, 5.5, 5.7, 5.8, 6.0, 6.2, 6.5, 6.8, 7.0, 7.2, 7.5, 7.8, 8.0, 8.5 or any pH therebetween. The pH can be controlled by adding a base such as ammonium hydroxide or sodium hydroxide or by adding an acid such as phosphoric acid.

[0140] The fermentation process of the present invention can be carried out over a period of about 1 to 90 days, or any period therebetween, such as 3 to 30 days, or any number of days therebetween, 3 to 8 days, or any number of days therebetween, or 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 40, 50, 60, 70, 80 or 90 days, or any number of days therebetween.

[0141] The fermentation processes of the present invention can be performed in a culture having a volume of at least 0.5 liter, such as about 0.5 to about 1,000,000 liters or any amount therebetween, such as 5 to about 400,000 liters or any amount therebetween, 20 to about 200,000 liters or any amount therebetween, or 2,000 to about 200,000 liters or any amount therebetween, or about 0.5, 1, 10, 50, 100, 200, 400, 600, 800, 1000, 2000, 4000, 6000, 8000, 10,000, 15, 2000, 2000, 3000, 4000, 5000, 6000, 8000, 10,000, 15 ... , 500,000, 750,000 or 1,000,000 liters in volume or any amount therebetween.

[0142] Fermentation process of the present invention can be performed aerobically in the presence of oxygen, or anaerobically in the absence of oxygen. For example, the process can be performed aerobically so that air or oxygen is provided to the deep liquid culture at a surface gas velocity of about 0.001 to about 100 cm / s or any rate therebetween, for example, any rate of about 0.01 to about 20 cm / s or any rate therebetween. An alternative parameter for measuring aeration rate known to those skilled in the art is vessel volume / minute (vvm). In fermentation process of the present invention, air or oxygen is provided to the deep liquid culture at a rate of about 0.5 to about 5 vvm or any rate therebetween. As required and as known to those skilled in the art, a defoamer (silicone or non-silicone-based) can be added to control excessive foaming in the process.

[0143] As used herein, the term "specific productivity", alternatively expressed as "qp", refers to the rate at which one or more jasmonates are produced by a given mass of recombinant host cells. Typically, the specific productivity of a fermentation process is expressed as mg protein / g host cell / hour (mg protein / g cell / h) and is calculated by measuring the concentration of jasmonates in mg / L in the culture filtrate (the culture medium from which the recombinant cells have been removed) and dividing by the concentration of cultured cells in the culture medium (in g dry weight / L) and then dividing by the total time in h since the feed solution was initially provided to the culture. The fermentation process of the present invention may also be characterized by a "maximum productivity" (or "maximum qp"), which is the highest value qp calculated during the course of the fermentation process, or by an "average productivity" (or "average qp"), which is the average of all qp values ​​calculated during the course of the fermentation process.

[0144] In some embodiments, a fermentation process according to the invention in which one or more jasmonates are produced by a cell culture overexpressing a polypeptide having 12-oxophytodienoate reductase (OPR) activity relative to a corresponding parental host cell shows at least a 50% increase in the maximum specific productivity (qp) shown by an equivalent process using a recombinant host cell derived from the parental cell. For example, such a fermentation process can show an increase in the maximum specific productivity (qp) of at least 50%, 60%, 70%, 80%, 90%, 100%, 150%, 200%, 300%, 400%, 500% or more relative to an equivalent process using a recombinant host cell derived from the parental host cell.

[0145] As used herein, the term "equivalent fermentation process" or "equivalent process" refers to a fermentation process in which a parent fungal cell is cultured under the same or nearly the same conditions of medium composition, time, cell density, temperature and pH as those used to culture isolated fungal cells derived from the parent fungal cell.

[0146] After cultivation, the product, such as jasmonic acid, can be extracted directly from the liquid culture medium. In addition, solids, such as cells, can be removed from the culture medium by centrifugation or membrane filtration, and the product can be collected and purified by ion exchange, concentration, distillation and crystallization methods.

[0147] Although the foregoing invention has been described in some detail by way of illustration and example for the purpose of understanding, it is obvious to those skilled in the art that certain changes and modifications may be practiced. Therefore, the description and examples should not be construed as limiting the scope of the invention as defined by the appended claims.

[0148] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the present disclosure belongs. Although preferred materials and methods are described below, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present disclosure.

[0149] The present disclosure will be more fully understood after considering the following non-limiting examples. It should be understood that, although the preferred embodiments of the subject technology are indicated, these examples are provided only by way of illustration. Based on the above discussion and these examples, those skilled in the art can determine the basic characteristics of the subject technology, and without departing from its spirit and scope, various changes and modifications of the subject technology can be prepared to adapt it to various uses and conditions. Example

[0150] The subject technology is further defined in the following examples. It should be understood that, although the preferred embodiments of the subject technology are indicated, these examples are provided only by way of illustration. Based on the above discussion and these examples, those skilled in the art can determine the basic characteristics of the subject technology, and without departing from its spirit and scope, various changes and modifications of the subject technology can be prepared to adapt it to various uses and conditions.

[0151] Example 1

[0152] Genomic and transcriptomic analysis was performed on the jasmonic acid-producing fungal species Lasiodiplodia iraniensis (Zheng et al., 2019), leading to the identification of many candidate sequences homologous to plant OPR genes (Schaller and Weiler, 1997). The candidate genes with N-terminal His tags were then expressed in E. coli bacteria, and the product proteins were purified using a Ni-NTA purification system. An HPLC-based OPR activity assay was used to screen candidate proteins, and the results showed that g5119 (SEQ ID NO: 2) encodes 12-oxophytodienoate reductase (SEQ ID NO: 1) in Lasiodiplodia iraniensis.

[0153] Codon optimized g5119 (SEQ ID NO: 3) was synthesized by Gene Universal Inc. (Newark, Delaware) and cloned into the pET-28a vector (Novagen, Wisconsin) between the NdeI and XhoI sites. The resulting construct was transformed into BL21 (DE3) competent E. coli cells for expression. In a typical experiment, an overnight culture was used to inoculate liquid Luria-Bertani (LB) medium (2%) containing 100 mg / L carbenicillin. The culture was first grown at 37°C to an OD of 1. 600 0.6, then cooled to 16°C. 1 mM IPTG was then added to induce protein expression. After incubation at 16°C for 18 hours, the cells were harvested by centrifugation and stored at -80°C until use.

[0154] Total soluble protein was extracted from frozen cells using B-PER (trademark) bacterial cell lysis reagent (Thermo Fisher Scientific, Massachusetts) according to the manufacturer's instructions and further purified by Ni-NTA column (Qiagen, Maryland) as described above. Figure 1 Depicted in A. The purified g5119 protein was visualized on an SDS-PAGE gel, as shown in Figure 1 Depicted in B.

[0155] OPR activity assays were performed in 100 mM K-Pi buffer pH 7.0 containing 50 mg / L OPDA (Cayman Chemical, Michigan), 1 mM NADPH and purified g5119 protein. The reaction was stopped by adding HCl to pH 2 and followed by ethyl acetate extraction. The ethyl acetate phase was used for HPLC analysis.

[0156] HPLC analysis was performed on a Thermo Scientific Vanquish UHPLC system using an Acclaim (trademark) 120, C18 column (3 μm 120A, 3×150 mm). The mobile phase was: A, 0.1% TFA (trifluoroacetic acid) and B, acetonitrile with the following gradient: 0-5 minutes, 5% B; 5-9 minutes, 5-80% B; 9-13 minutes, 80% B; 13-14 minutes, 80-5% B; 14-17 minutes, 5% B. The detector wavelength for OPDA and OPC8 was set to 200 nm. Figure 2 A typical HPLC profile of a reaction catalyzed by g5119 is included. Figure 3Included is LC / MS analysis of the g5119 catalyzed reactions. In #3-5199, the reaction was catalyzed by g5199 in the absence of NADPH; in #6-5199, the reaction was catalyzed by g5199 in the presence of 1 mM NADPH, where no OPDA was detected after the reaction, indicating complete conversion.

[0157] Example 2

[0158] Agrobacterium tumefaciens-mediated transformation (ATMT) has long been used to transfer genes to a wide variety of fungi, including plant pathogenic fungi or symbiotic fungi (Vieira and Camilo, 2011). Agrobacterium tumefaciens has the natural ability to transfer segments of its Ti plasmid (called 'T-DNA') to plant or fungal cells, becoming randomly integrated into nuclear chromosomes. Binary vector systems can be used by ATMT. In this system, T-DNA and virulence regions are separated in 2 different plasmids, allowing easier genetic manipulation of smaller binary vectors containing T-DNA (Hoekema et al., 1983) in mushrooms, industrial fungi and biocontrol fungi (Ando et al., 2009; Sharma and Kuhad, 2010; Vieira and Camilo, 2011). Agrobacterium tumefaciens has the natural ability to transfer segments of its Ti plasmid (called 'T-DNA') to plant or fungal cells, becoming randomly integrated into nuclear chromosomes. Binary vector systems can be used by ATMT. In this system, the T-DNA and the virulence region are separated in two different plasmids, allowing easier genetic manipulation of the smaller binary vector containing the T-DNA (Hoekema et al., 1983).

[0159] As reported in the literature, ATMT was successfully performed in Lasiodiplodia theobromae (Muniz et al., 2014). Similar ATMT-based transformation protocols can be used to achieve expression and / or overexpression of gs5119-like proteins in Lasiodiplodia species such as Lasiodiplodi arianiensis.

[0160] Source and growth conditions of microorganisms

[0161] Wild-type L. iraniensis was stored on potato dextrose agar (PDA) at 5°C (Muniz et al., 2012). E. coli strain DH5α was used as a host for plasmid DNA propagation. Agrobacterium tumefaciens strain AGL1 containing binary vectors was maintained in Luria-Bertani (LB) medium supplemented with 250 μg / mL spectinomycin.

[0162] Plasmids

[0163] The backbone of pPm43GW (VIB, Gent, Belgium) was used to construct a binary vector for transformation of L. iraniensis. It contains a cassette in which the Escherichia coli hygromycin B (Hyg B) phosphotransferase (hph) resistance gene is under the control of the Aspergillus nidulans trpC promoter and a PtGFP cassette containing the promoter toxA-5'-UTR from Pyricularia tritici, a gene encoding a polynucleotide sequence encoding a gs5119-like protein ("gs5119"), and a nos terminator (Tnos). The resulting plasmid was named pPm43GW-gs5119-HPH. Figure 5 As shown in , gs5119 is placed under the control of PtoxA-5'-UTR, and LB and RB represent left and right borders.

[0164] This vector was transformed into Agrobacterium tumefaciens strain AGL1 using electroporation. Bacteria were spread onto LB plates supplemented with 250 μg / mL spectinomycin and incubated at room temperature for 2 days.

[0165] Testing for hygromycin B susceptibility

[0166] Before transformation, cultures obtained from germinated organospores (Muniz et al., 2012) were submitted to a minimum inhibitory concentration of hygromycin B. Cultures were inoculated on PDA containing different concentrations of hygromycin B (0, 50, 100, 150, 200, 250 and 300 μg / mL) and then incubated at 28°C for 14 days. For each treatment, 5 culture dishes were used. A concentration of hygromycin B that completely inhibited mycelial growth on all 5 plates was used in the transformation experiment. This test was repeated twice.

[0167] Fungal transformation

[0168] Transformation was performed as previously described (de Groot et al., 1998; dos Reis et al., 2004; Staats et al., 2007) with minor modifications. An isolated Agrobacterium tumefaciens colony (strain AGL1) was grown overnight at 27°C, 150 rpm in 20 mL LB mannitol (10 g bacto-peptone, 5 g yeast extract, 2.5 g NaCl, 10 g mannitol) supplemented with 250 μg / mL spectinomycin and 75 μg / mL carbenicillin. Subsequently, the Agrobacterium tumefaciens cells were centrifuged and suspended in 20 mL of minimal medium (MM) (11.4 mM K2HPO4, 10.6 mM KH2PO4, 2.4 mM MgSO4-7H2O, 5.4 mM NaCl, 68 μM CaCl2-2H2O, 6.6 μM FeSO4, 1.74 mM ZnSO4-7H2O, 2 mM CuSO4-5H2O, 8 mM H3BO3, 2.96 mM MnSO4-H2O, 2 mM Na2MoO4-2H2O, 6.3 mM NH4NO3, 11 mM glucose), wherein the minimal medium contained 75 μg / mL carbenicillin and 250 μg / mL spectinomycin. After incubation overnight at 27°C, 150 rpm, the culture was diluted to an OD of 0.1 in 20 mL of induction medium (IM) (same as MM but modified with 40 mM (2-[N-morpholino]ethanesulfonic acid), 54 mM glycerol, and 200 μL acetosyringone (AS). 660 0.15, the induction medium contained 75 μg / mL carbenicillin and 250 μg / mL spectinomycin. The culture was returned to the same growth conditions until OD 660 reached 0.25. Monospore strains of L. iraniensis were grown on PDA at 28°C for 14 days. Spores were obtained according to the method of Muniz et al. (2012), collected by flooding the culture dishes with sterile water and counted under a microscope equipped with a Neubauer chamber. The final spore concentration was adjusted to about 10 in saline solution. 7 Spores / mL. Co-cultivation of Agrobacterium tumefaciens and organospore solution was performed by adding 100 μL bacterial culture to 100 μL fungal suspension. In the presence and absence of 200 μL AS, this mixture was placed on a square cellulose membrane (120 x 120 x 17 mm) on a co-cultivation medium (IM+1.5% agar) and incubated for 2 days at 22°C. After 2 days, the sample was transferred to a selection medium (SM) improved with 150 μg / mL hygromycin and 200 μM / mL cefotaxime to inhibit the growth of Agrobacterium tumefaciens. The colonies (presumed transformants) that appeared after incubation at 28°C were transferred to PDA with 150 μg / mL hygromycin and incubated at 28°C.

[0169] Transgenic stability and viability of Lasiodiplodia transformants

[0170] All transgenic isolates of ATMT from Lachnosporium were subcultured on PDA modified with 150 μg hygromycin. The plates were incubated at 28°C for 8 days. Colony growth rates were checked every 2 days. After 8 days, spore production was tested. This procedure was repeated 3 times in a row. Fungal colonies were then analyzed for GFP expression by fluorescence microscopy. The minimum inhibitory concentration of Hyg B for L. iraniensis was determined by culturing single spore cultures on PDA containing different Hyg B concentrations. The minimum inhibitory concentration was then used for the initial selection of transformants.

[0171] Industrial Applicability

[0172] The present disclosure has applicability in the nutraceutical and pharmacology industries.The present disclosure generally relates to methods for the biosynthetic production of jasmonic acid, for example via improved microbial strains.

[0173] Sequence of interest

[0174] SEQ ID NO:1

[0175] Amino acid sequence of wild-type 12-oxophytodienoate reductase gs5119 in Lasiodiplodia iranensis:

[0176]

[0177] SEQ ID NO:2

[0178] DNA sequence of wild-type 12-oxophytodienoate reductase gs5119 in Lasiodiplodia iranensis:

[0179]

[0180] SEQ ID NO:3

[0181] DNA sequence of wild-type 12-oxophytodienoate reductase gs5119 in Lasiodiplodia iranensis codon-optimized for E. coli:

[0182]

Claims

1. A recombinant host cell comprising a metabolic pathway for producing jasmonic acid, wherein the host cell overexpresses a polypeptide having 12-oxophytodienoate reductase (OPR) activity relative to a corresponding parent host cell, wherein the polypeptide comprises an amino acid sequence having at least 90% identity to the amino acid sequence shown in SEQ ID NO:

1.

2. The recombinant host cell according to claim 1, wherein overexpression of the polypeptide having OPR activity has been provided by replacing the natural promoter of the gene expressing the polypeptide having OPR activity with a promoter having a higher expression level than the natural promoter.

3. The recombinant host cell according to claim 2, wherein the natural promoter is replaced with a ToxA promoter of Pyrenophora tritici-repentis or a ToxB promoter of Pyrenophora tritici-repentis.

4. The recombinant host cell according to any one of claims 1 to 3, wherein overexpression of the polypeptide having OPR activity has been provided by recombinantly introducing into the host cell at least one copy of an exogenous polynucleotide sequence encoding a polypeptide having OPR activity.

5. The recombinant host cell according to any one of claims 1 to 4, wherein the host cell is selected from bacteria, yeast, filamentous fungi, cyanobacteria and plant cells.

6. The recombinant host cell of any one of claims 1 to 5, wherein the host cell is a filamentous fungus belonging to a genus selected from the group consisting of Lasiodiplodia, Rhizopus, Fusidium, Gibberella, Trichoderma, Hypocrea, Aspergillus, Fusarium, Penicillium, Neurospora, Chaetomium, aetomium, Acremonium, Glomerella, Myceliophthora, Sporotrichum, Thielavia, Chrysosporium, Corynascus, Ctenomyces, Verticillium, Cordyceps, Nectria, and Magnaporthe.

7. The recombinant host cell of claim 6, wherein the host cell is a Lasiodiplodiairaniensis cell.

8. The recombinant host cell of any one of claims 1 to 5, wherein the host cell is selected from the group consisting of Escherichia; Salmonella; Bacillus; Acinetobacter; Corynebacterium; Methylosinus; Methylomonas; Rhodococcus; Pseudomonas; Rhodobacter ; Synechocystis; Aspergillus; Arthrobotlys; Brevibacteria; Microbacterium; Arthrobacter; Citrobacter; Klebsiella; Pantoea; Salmonella; Corynebacterium and Clostridium.

9. The recombinant host cell of any one of claims 1 to 5, wherein the host cell is a cell isolated from a plant selected from the group consisting of soybean, rapeseed, sunflower, cotton, corn, tobacco, alfalfa, wheat, barley, oats, sorghum, rice, broccoli, cauliflower, cabbage, parsnips, melons, carrots, celery, parsley, tomatoes, potatoes, strawberries, peanuts, grapes, grass seed crops, sugar beets, sugar cane, beans, peas, rye, flax, hardwood trees, softwood trees, forage grasses, Arabidopsis thaliana, rice (Oryza sativa), barley (Hordeum yulgare), switchgrass (Panicum vigratum), Brachypodium spp., Brassica spp., and Crambe abyssinica.

10. A biosynthetic method for producing jasmonic acid, wherein include: Cultivating the recombinant host cell according to claim 1 in a culture medium; and Jasmonic acid is recovered from at least one of the recombinant cells and the culture medium.

11. A recombinant host cell comprising a metabolic pathway for producing jasmonic acid, wherein relative to a corresponding parental host cell, the host cell overexpresses a gene encoding a polypeptide having 12-oxophytodienoate reductase (OPR) activity, wherein the gene comprises a polynucleotide sequence having at least 90% identity to the polynucleotide sequence shown in SEQ ID NO:

2.

12. The recombinant host cell according to claim 11, wherein overexpression of a gene encoding a polypeptide having 12-oxophytodienoate reductase (OPR) activity is provided by replacing the native promoter of the gene expressing the polypeptide having OPR activity with a promoter having a higher expression level than the native promoter.

13. The recombinant host cell according to claim 12, wherein the natural promoter is replaced with a ToxA promoter of Pyricularia tritici or a ToxB promoter of Pyricularia tritici.

14. The recombinant host cell according to claim 11, wherein overexpression of a gene encoding a polypeptide having 12-oxophytodienoate reductase (OPR) activity is provided by recombinantly introducing into the host cell at least one copy of an exogenous sequence encoding a polypeptide having OPR activity.

15. The recombinant host cell according to any one of claims 11 to 14, wherein the host cell is selected from bacteria, yeast, filamentous fungi, cyanobacteria and plant cells.

16. The recombinant host cell of any one of claims 11 to 14, wherein the host cell is a filamentous fungus belonging to a genus selected from the group consisting of Lachnospermum, Rhizopus, Fusidium, Gibberella, Trichoderma, Hypocrea, Aspergillus, Fusarium, Penicillium, Neurospora, Chaetomium, Acremonium, Myceliophthora, Sporotrichum, Thielavia, Chrysosporium, Corymbinocytosis, Ctenophora, Verticillium, Cordyceps, Echinopsium, and Gigantopithecus.

17. The recombinant host cell of claim 16, wherein the host cell is a Lasiodiplodiairaniensis cell.

18. The recombinant host cell of any one of claims 11 to 14, wherein the host cell is selected from the group consisting of Escherichia; Salmonella; Bacillus; Acinetobacter; Corynebacterium; Methylcampus; Methylomonas; Rhodococcus; Pseudomonas; Rhodobacter; Synechocystis; Aspergillus; Arthrospora; Brevibacterium; Microbacterium; Arthrobacter; Citrobacter; Klebsiella; Pantoea; Salmonella; Corynebacterium and Clostridium.

19. The recombinant host cell of any one of claims 11 to 14, wherein the host cell is a cell isolated from a plant selected from the group consisting of soybean, rapeseed, sunflower, cotton, corn, tobacco, alfalfa, wheat, barley, oats, sorghum, rice, broccoli, cauliflower, cabbage, parsnips, melons, carrots, celery, parsley, tomatoes, potatoes, strawberries, peanuts, grapes, grass seed crops, sugar beets, sugar cane, beans, peas, rye, flax, hardwood trees, softwood trees, forage grasses, Arabidopsis thaliana, rice (Oryza sativa); barley; switchgrass (Pachyrhizopus virginiana); Brachypodium; Brassica; and crambe.

20. A biosynthetic method for producing jasmonic acid, the method include: Cultivating the recombinant cell according to claim 11 in a culture medium; and Jasmonic acid is recovered from at least one of the recombinant cells and the culture medium.

21. A biosynthetic method for producing a polypeptide having 12-oxophytodienoate reductase (OPR) activity, the method comprising: include: Cultivating the recombinant cell according to claim 11; and A polypeptide having 12-oxophytodienoate reductase (OPR) activity is recovered from at least one of the recombinant cells and the culture medium.

22. A vector comprising a polynucleotide sequence having at least 90% identity to the polynucleotide sequence shown in SEQ ID NO:

2.

23. The vector of claim 22, further comprising a promoter operably linked to a polynucleotide sequence having at least 90% identity to the polynucleotide sequence shown in SEQ ID NO: 2, wherein the promoter has an expression level higher than the native promoter of the gene expressing the polynucleotide sequence shown in SEQ ID NO:

2.

24. A recombinant host cell that overexpresses a gene encoding a polypeptide having 12-oxophytodienoate reductase (OPR) activity relative to a corresponding parental host cell, wherein the gene comprises a polynucleotide sequence having at least 90% identity to the polynucleotide sequence shown in SEQ ID NO:

3.

25. The recombinant host cell of claim 24, wherein the recombinant host cell is a genetically modified E. coli cell.

26. A biosynthetic method for producing jasmonic acid, wherein include: Cultivating the recombinant host cell according to claim 24; and Jasmonic acid is recovered from at least one of the recombinant cell and the culture medium.